Autoinjector Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Autoinjector Contract Manufacturing Market Size, Share & Trends Analysis Report, By Service Type (Device Design and Development Services, Component Molding and Sub-Assembly Manufacturing, Final Assembly, Drug-Device Integration and Packaging, Testing, Verification and Regulatory Support), By Device Type (Disposable Prefilled Autoinjectors, Reusable and Electromechanical Autoinjectors, Emergency and Rescue Autoinjectors), By Therapeutic Application (Metabolic and GLP-1 Therapies, Immunology and Biologics, Emergency Medicine and Anaphylaxis, Other Chronic Therapies), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The autoinjector contract manufacturing market covers outsourced design, component molding, sub-assembly, final assembly with drug-device integration, packaging and verification services for disposable, reusable and emergency autoinjectors supplied to pharmaceutical companies, platform owners and biosimilar manufacturers. Sales of proprietary device platforms and pen injectors, and captive manufacturing by pharmaceutical companies, are excluded.
Demand has surged with the growth of self-administered biologics and metabolic therapies, particularly incretin drugs whose volumes have outstripped assembly capacity and forced originators to reserve lines years in advance and to fund dedicated plants at contract manufacturers. Sponsors outsource because high-volume automated assembly, injection molding of precision components and combination-product verification require capital and expertise that fall outside their core competence. Providers are adding automated final assembly lines, expanding molding capacity in the United States, Europe and Asia, integrating with fill-finish partners for complete combination products and building capabilities for electromechanical and connected devices. Component supply constraints, regulatory requirements for human factors and essential performance testing and the entry of biosimilar autoinjectors shape competitive dynamics.
North America and Europe host most capacity and demand, with Asia expanding through Chinese, Indian and Southeast Asian manufacturing. Competition involves medical device contract manufacturers, drug delivery platform companies offering manufacturing services and pharmaceutical CDMOs integrating assembly.
The InsightAce study delivers revenue forecasts in US$ across all service type, device type, therapeutic application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Autoinjector Contract Manufacturing Market Snapshot
Chapter 4. Global Autoinjector Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Device Design and Development Services
5.2.2. Component Molding and Sub-Assembly Manufacturing
5.2.3. Final Assembly, Drug-Device Integration and Packaging
5.2.4. Testing, Verification and Regulatory Support
Chapter 6. Market Segmentation 2: By Device Type Estimates & Trend Analysis
6.1. Device Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type:
6.2.1. Disposable Prefilled Autoinjectors
6.2.2. Reusable and Electromechanical Autoinjectors
6.2.3. Emergency and Rescue Autoinjectors
Chapter 7. Market Segmentation 3: By Therapeutic Application Estimates & Trend Analysis
7.1. Therapeutic Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Application:
7.2.1. Metabolic and GLP-1 Therapies
7.2.2. Immunology and Biologics
7.2.3. Emergency Medicine and Anaphylaxis
7.2.4. Other Chronic Therapies
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Device Platform Owners
8.2.3. Generic and Biosimilar Manufacturers
Chapter 9. Autoinjector Contract Manufacturing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Phillips-Medisize (Molex, Koch Industries)
11.2. Sanner Group (Gilero and Springboard Pro)
11.3. Ypsomed AG
11.4. SHL Medical AG
11.5. Becton, Dickinson and Company
11.6. West Pharmaceutical Services, Inc.
11.7. Gerresheimer AG
11.8. Owen Mumford Ltd.
11.9. Nemera
11.10. Recipharm AB
11.11. Vetter Pharma International GmbH
11.12. Terumo Pharmaceutical Solutions
11.13. Jabil Inc. (Healthcare)
11.14. Flex Ltd. (Health Solutions)
11.15. Congruence Medical Solutions
圖表清單 List of Tables & Figures
Table 1. Global Autoinjector Contract Manufacturing Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Autoinjector Contract Manufacturing Market Segmentation and Scope Overview
Table 2. Global Autoinjector Contract Manufacturing Market Revenue Forecast by Device Type, 2026-2035 (US$ Mn)
Figure 2. Global Autoinjector Contract Manufacturing Market Share by Service Type, 2026 & 2035
Table 3. Global Autoinjector Contract Manufacturing Market Revenue Forecast by Therapeutic Application, 2026-2035 (US$ Mn)
Figure 3. Autoinjector Manufacturing Value Chain from Component Molding to Combination Product Release
Table 4. Global Autoinjector Contract Manufacturing Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Autoinjector Assembly Capacity Additions and Reservation Commitments, 2024-2030
Table 5. Global Autoinjector Contract Manufacturing Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Autoinjector Contract Manufacturing Growth Opportunity Analysis
Table 6. North America Autoinjector Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Autoinjector Contract Manufacturing Market Participants
Table 7. Europe Autoinjector Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Autoinjector Contract Manufacturing Market
Table 8. Asia Pacific Autoinjector Contract Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Device Complexity Trends: Disposable, Reusable, Connected and Emergency Formats
Table 9. Strategic Developments of Leading Autoinjector Contract Manufacturing Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們